Literature DB >> 2039324

Bronchogenic carcinoma with chest wall invasion.

M S Allen1, D J Mathisen, H C Grillo, J C Wain, A C Moncure, A D Hilgenberg.   

Abstract

Bronchogenic carcinoma with chest wall involvement continues to present a major clinical challenge. We have treated 52 patients since 1973, excluding those with superior sulcus tumors. There were 37 male and 15 female patients with an average age of 62.9 years. Chest pain was an initial symptom in 37%. All patients had negative mediastinoscopy results. Squamous cell carcinoma was present in 53% and adenocarcinoma in 35%. The median number of ribs resected was two (range, one to six), and only 2 patients required chest wall reconstruction. Pathologic staging was T3 N0 M0 in 83% and T3 N1 M0 in 17%. Operative mortality was 3.8%. Absolute 5-year survival was 26.3%. Patients who had N1 disease had a 5-year survival of only 11%. Radiation therapy was employed in 46% for positive nodes or close margins. Bronchogenic carcinoma with chest wall invasion remains potentially curable if N2 nodes are not involved. The role of radiation therapy has not been clearly defined. Morbidity and mortality should be minimal.

Entities:  

Mesh:

Year:  1991        PMID: 2039324     DOI: 10.1016/0003-4975(91)91011-j

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  11 in total

1.  Assessment of extensive surgery for locally advanced lung cancer. Safety and efficacy of induction therapy.

Authors:  H Niwa; K Nakamae; T Yamada; H Kani; K Maemoto; T Mizuno
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-09

2.  Number of Ribs Resected is Associated with Respiratory Complications Following Lobectomy with en bloc Chest Wall Resection.

Authors:  Nicole M Geissen; Robert Medairos; Edgar Davila; Sanjib Basu; William H Warren; Gary W Chmielewski; Michael J Liptay; Andrew T Arndt; Christopher W Seder
Journal:  Lung       Date:  2016-04-23       Impact factor: 2.584

3.  Clinical Characteristics of Resected T3 Non-small Cell Lung Cancer Characterized by Parietal Pleural Invasion or Chest Wall Invasion.

Authors:  Takeshi Hanagiri; Shinji Shinohara; Masaru Takenaka; Hidehiko Shimokawa; Yoshika Nagata; Makoto Nakagawa; Hidetaka Uramoto; Tomoko So; Fumihiro Tanaka
Journal:  Indian J Surg       Date:  2012-07-28       Impact factor: 0.656

4.  Chest wall resection and reconstruction for lung cancer: surgical techniques and example of integrated multimodality approach.

Authors:  Mauro Loi; Antonio Mazzella; Isacco Desideri; Ludovic Fournel; Emelyne Canny Hamelin; Philippe Icard; Antonio Bobbio; Marco Alifano
Journal:  J Thorac Dis       Date:  2020-01       Impact factor: 2.895

5.  Is myocutaneous flap alone sufficient for reconstruction of chest wall osteoradionecrosis?

Authors:  Mohamed Makboul; Mohamed A K Salama Ayyad
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-05-25

6.  Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer.

Authors:  Usman Ahmad; Traves D Crabtree; Aalok P Patel; Daniel Morgensztern; Cliff G Robinson; A Sasha Krupnick; Daniel Kreisel; David R Jones; G Alexander Patterson; Bryan F Meyers; Varun Puri
Journal:  Ann Thorac Surg       Date:  2017-04-19       Impact factor: 4.330

Review 7.  Extended resection for higher-stage non-small-cell lung cancer.

Authors:  J D Luketich; D E van Raemdonck; R J Ginsberg
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

8.  Combined pulmonary and thoracic wall resection for stage III lung cancer.

Authors:  S S Shah; P Goldstraw
Journal:  Thorax       Date:  1995-07       Impact factor: 9.139

9.  Surgical treatment of 125 patients with non-small cell lung cancer and chest wall involvement.

Authors:  C C Pitz; A Brutel de la Rivière; H R Elbers; C J Westermann; J M van den Bosch
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

10.  The prognostic factors of resected non-small cell lung cancer with chest wall invasion.

Authors:  Chang Young Lee; Chun Sung Byun; Jin Gu Lee; Dae Joon Kim; Byoung Chul Cho; Kyung Young Chung; In Kyu Park
Journal:  World J Surg Oncol       Date:  2012-01-12       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.